Calhoun DA, Oparil S.  Treatment of hypertensive crises. N Engl J Med . 1990;;323:1177-1183.
Houston MC.  Pathophysiology, clinical aspects, and treatment of hypertensive crises. Prog Cardiovasc Dis . 1989;;32:99-148.
Bertel O, Conen LD.  Treatment of hypertensive emergencies with the calcium channel blocker nifedipine. Am J Med . 1985;;79(
(suppl 4A)
):31-35.
Jaker M, Atkin S, Soto M, Schmid G, Brosch F.  Oral nifedipine vs oral clonidine in the treatment of urgent hypertension. Arch Intern Med . 1989;; 149:260-265.
Del Castillo AC, Rodriguez M, Gonzalez E, Rodriguez F, Estruch J.  Dose-response effect of sublingual captopril in hypertensive crises. J Clin Pharmacol . 1988;;28:667-670.
Hayes JM.  Prazosin in severe hypertension: effect on blood pressure, plasma renin activity and in hypertensive emergencies. Med J Aust . 1977;; 2(
(suppl 2)
):30-32.
Garcia JY, Vidt DG.  Current management of hypertensive emergencies. Drugs . 1987;;34:263-278.
Strandgaard S, Olesen J, Skinhoj E, Lassen NA.  Autoregulation of brain circulation in severe arterial hypertension. BMJ . 1973;;1:507-510.
Kontos HA.  Regulation of the cerebral circulation. Annu Rev Physiol . 1981;;43:397-407.
Strandgaard S.  Autoregulation of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation . 1976;;53:720-727.
Gifford RW Jr.  Effect of reducing elevated blood pressure on cerebral circulation. Hypertension . 1983;;5(
(suppl III)
):III-17-III-20.
Rubenstein EB, Escalante C.  Hypertensive crisis. Crit Care Clin . 1989;;5:477-495.
Gifford RW Jr, Westbrook E.  Hypertensive encephalopathy: mechanisms, clinical features, and treatment. Prog Cardiovasc Dis . 1974;;17:115-124.
Lassen NA, Agnuli A.  The upper limit of autoregulation of cerebral blood flow on the pathogenesis of hypertensive encephalopathy. Scand J Clin Lab Invest . 1972;;30:113-116.
Tettenborn D, Dycka J.  Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage. Stroke . 1990;;21(
(suppl IV)
):IV-85-IV-89.
Tettenborn D, Dycka J, Volberg E, Düdden P.  Blood pressure and heart rate during treatment with nimodipine in patients with subarachnoid hemorrhage. Neurochirurgia . 1985;;28:84-86.
Nibbelink DW.  Cooperative Aneurysm Study: antihypertensive and antifibrinolytic therapy following subarachnoid hemorrhage from ruptured intracranial aneurysm. In: Whisnant JP, Sandok BA, eds. Cerebral Vascular Diseases . New York, NY: Grune and Stratton; 1975;:155-165.
Biller J, Godersky JC, Adams HP.  Management of aneurysmal subarachnoid hemorrhage. Stroke . 1988;;19:1300-1305.
Brott T, Reed RL.  Intensive care for acute stroke in the community hospital setting: the first 24 hours. Stroke . 1989;;20:694-697.
Feldmann E. Intracerebral Hemorrhage: Current Concepts of Cerebrovascular Disease and Stroke . Dallas, Tex: American Heart Association; 1991;;26(1).
Gelmers HJ, Gorter K, de Weerdt CJ, Wiezer HJA.  A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med . 1988;;318:203-207.
Martinez-Vila E, Guillén F, Villanueva JA, et al.  Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction. Stroke . 1990;;21:1023-1028.
Cohn JN, Burke LP.  Nitroprusside. Ann Intern Med . 1979;;91:752-757.
Horowitz D, Sjoerdsma A.  Some interrelationships between elevation of blood pressure and angina pectoris. Proc Counc High Blood Pres Res Am Heart Assoc . 1965;;12:39-48.
James TN, Isobe JH, Urthaler F.  Analysis of components in a cardiogenic chemoreflex. Circulation . 1975;;52:179-192.
Eckstein RW, Shintani F, Rowen HE Jr, Shimomura K, Ohya N.  Identification of left coronary blood supply of aortic bodies in anesthetized dogs. J Appl Physiol . 1971;;30:488-492.
Mann T, Cohn PF, Holman L, et al.  Effect of nitroprusside on regional myocardial blood flow in coronary artery disease: results in 25 patients and comparison with nitroglycerin. Circulation . 1978;;57:732-738.
Flaherty JT.  Comparison of intravenous nitroglycerin and sodium nitroprusside in acute myocardial infarction. Am J Med . 1983;;74(
(suppl 6B)
):53-60.
Asfoura JY, Vidt DG.  Acute aortic dissection. Chest . 1991;;99:724-729.
Wheat MW.  Acute dissection of the aorta. Cardiovasc Clin . 1987;;17:241-262.
Hogan PJ.  Medical management of dissecting thoracic aneurysms. Tex Heart Inst J . 1990;;17:281-288.
Clary C, Schweizer E.  Treatment of MAOI hypertensive crisis with sublingual nifedipine. J Clin Psychiatry . 1987;;48:249-250.
Gifford RW Jr, August P, Chesley LC, et al.  National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol . 1990;;163:1689-1712.
Flaherty JT, Magee PA, Gardner TL, Potter A, MacAllister NP.  Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary artery bypass surgery. Circulation . 1982;;65:1072-1077.
Stinson EB, Holloway EL, Derby G, et al.  Comparative hemodynamic responses to chlorpromazine, nitroprusside, nitroglycerin, and trimethaphan immediately after open-heart operations . Circulation . 1975;;51(
(suppl I)
):I-26-I-33.
Estafanous FG, Tarazi RC.  Systemic arterial hypertension associated with cardiac surgery. Am J Cardiol . 1980;;46:685-694.
Gifford RW Jr.  Management and treatment of essential hypertension, including malignant hypertensive emergencies. In: Genest J, Kuchel O, Hamet P, Cantin M, eds. Hypertension . New York, NY: McGraw-Hill International Book Co; 1983;:1127-1170.
 The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med . 1988;;148:1023-1038.
McAllister RG.  Kinetics and dynamics of nifedipine after oral and sublingual doses. Am J Med . 1986;;81(
(suppl 6A)
):2-5.
van Harten J, Burggraaf K, Danhof M, van Brummelen P, Breimer DD.  Negligible sublingual absorption of nifedipine. Lancet . 1987;;2:1363-1365.
Zeller KR, Kuhnert LV, Matthews C.  Rapid reduction of severe asymptomatic hypertension. Arch Intern Med . 1989;;149:2186-2189.
Nightingale SL.  New labeling for sodium nitroprusside emphasizes risk of cyanide toxicity. JAMA . 1991;;265:847.
Kumar GK, Dastoor FC, Robayo JR, Razzaque MA.  Side effects of diazoxide. JAMA . 1976;; 235:275-276.
Kanada SA, Kanada DJ, Hutchinson RA, Wu D.  Angina-like syndrome with diazoxide therapy for hypertensive crisis. Ann Intern Med . 1976;;84:696-699.
Koch-Weser J.  Diazoxide. N Engl J Med . 1976;;244:1271-1274.
Wilson DJ, Lewis RC, Vidt DG.  Control of severe hypertension with pulse diazoxide. Cardiovasc Clin . 1982;;12(
(2)
):79-91.
Paulson OB, Andersen AR, Vorstrup S.  Drugs in acute ischemic cerebrovascular lesion evaluated by regional blood flow measurements in the brain. Agressologie . 1987;;28:367-371.
Cressman MD, Vidt DG, Gifford RWJr, Moore WS, Wilson DJ.  Intravenous labetalol in the management of severe hypertension and hypertensive emergencies. Am Heart J . 1984;;107:980-985.
O'Mailia JJ, Sander GE, Giles TD.  Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med . 1987;;107:185-186.
Schwartz M, Naschitz JE, Yeshurun D, Sharf B.  Oral nifedipine in the treatment of hypertensive urgency: cerebrovascular accident following a single dose. Arch Intern Med . 1990;;150:686-687.
Fagan TC.  Acute reduction of blood pressure in asymptomatic patients with severe hypertension: an idea whose time has come and gone. Arch Intern Med . 1989;;149:2169-2170.
Ferguson RK, Vlasses PH.  How urgent is 'urgent' hypertension? Arch Intern Med . 1989;; 149:257-258.